Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HAYWARD, Calif.–(BUSINESS WIRE)–Jun 16, 2022–. Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the …
-
CV-19 Press
Stay Up To Date with COVID-19 Data
More than 22 million Americans have contracted the virus. Get the latest headlines from the Coronavirus Press today.
-
CV-19 Press
Stay Up To Date with COVID-19 Data
More than 22 million Americans have contracted the virus. Get the latest headlines from the Coronavirus Press today.
